Mark Cuban’s Cost Plus Drugs tackles expensive rare disease treatments

Mark Cuban’s Cost Plus Drugs says it can reduce manufacturing costs for custom rare disease drugs and n-of-1 gene therapies.

Source: Mark Cuban’s Cost Plus Drugs tackles expensive rare disease treatments | STAT